{"url":"https://lda.senate.gov/api/v1/filings/b3e467ca-7eb5-4591-bce9-e5aab0dd6253/","filing_uuid":"b3e467ca-7eb5-4591-bce9-e5aab0dd6253","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2021,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b3e467ca-7eb5-4591-bce9-e5aab0dd6253/print/","filing_document_content_type":"text/html","income":"45000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Shane Vicry","dt_posted":"2021-06-22T12:05:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 PENNSYLVANIA AVE NW","registrant_address_2":"Unit 1150","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105372,"url":"https://lda.senate.gov/api/v1/registrants/401105372/","house_registrant_id":null,"name":"THE KPM GROUP DC LLC","description":"lobby firm","address_1":"5331 16th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20011","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISA HESS","contact_telephone":"+1 434-933-2535","dt_updated":"2026-07-20T15:33:02.088040-04:00"},"client":{"id":210270,"url":"https://lda.senate.gov/api/v1/clients/210270/","client_id":101,"name":"ORPHAZYME US, INC.","general_description":"Development of Heat-Shock Protein response for treatment of neurodegenerative rare disease","client_government_entity":false,"client_self_select":null,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-12-16"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act\nH.R. 482/S. 350, Newborn Screening Reauthorization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72652,"prefix":null,"prefix_display":null,"first_name":"PATROSKI","nickname":null,"middle_name":null,"last_name":"LAWSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73276,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":92819,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"LANDES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}